Cathay Biotech (SH:688065) Zheng Quan Zhi Xing·2025-08-01 16:35Core Viewpoint - The nomination of Mr. Shang Jiangan as an independent director candidate for the third board of Shanghai Kaisa Biotechnology Co., Ltd. has been made, with the nominee meeting all necessary qualifications and independence requirements [1][5]. Summary by Sections Nomination and Qualifications - The nominee has a solid understanding of the operations of listed companies and is familiar with relevant laws and regulations, possessing over five years of necessary work experience in law, economics, accounting, finance, or management [1]. - The nominee has completed training and obtained relevant certification recognized by the stock exchange [1]. Independence Criteria - The nominee does not fall under any of the disqualifying conditions, such as holding significant shares in the company or being related to major shareholders [2]. - The nominee has not been involved in any significant business dealings with the company or its controlling shareholders [2]. Record of Conduct - The nominee has no adverse records, including administrative or criminal penalties from the China Securities Regulatory Commission in the last 36 months [3][4]. - The nominee has not been publicly reprimanded by the stock exchange or faced significant credit issues [4]. Additional Compliance - The nominee has passed the qualification review by the nomination committee of the third board of Shanghai Kaisa Biotechnology Co., Ltd. and has no conflicts of interest that could affect independent performance [4].